<DOC>
	<DOC>NCT00487123</DOC>
	<brief_summary>This study will evaluate the efficacy of the reminder device Remind CapÂ® in improving patients' compliance in the consumption of Valsartan +/- Hydrochlorothiazide (HCTZ) in the treatment of hypertension</brief_summary>
	<brief_title>Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Patients with hypertension that have newly started using Valsartan+/HCTZ Pregnancy or Hypersensitivity to Valsartan+/HCTZ Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Hypertension, compliance, Valsartan, hydrochlorothiazide (HCTZ)</keyword>
</DOC>